HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,136,000 | -38.8% | 264,990 | -19.3% | 0.10% | -10.0% |
| Q1 2022 | $34,555,000 | -44.0% | 328,442 | -42.6% | 0.11% | -29.0% |
| Q4 2021 | $61,693,000 | -11.2% | 572,506 | -9.7% | 0.16% | -6.6% |
| Q3 2021 | $69,439,000 | +33.2% | 633,911 | +13.9% | 0.17% | +35.0% |
| Q2 2021 | $52,128,000 | +13.9% | 556,683 | +12.0% | 0.12% | +2.5% |
| Q1 2021 | $45,755,000 | -17.6% | 497,125 | -34.5% | 0.12% | -16.7% |
| Q4 2020 | $55,528,000 | -12.3% | 759,096 | -6.8% | 0.14% | -21.7% |
| Q3 2020 | $63,291,000 | +1421.8% | 814,772 | +988.7% | 0.18% | +1214.3% |
| Q2 2020 | $4,159,000 | +602.5% | 74,836 | +274.2% | 0.01% | +1300.0% |
| Q1 2020 | $592,000 | +443.1% | 20,000 | +566.7% | 0.00% | – |
| Q4 2019 | $109,000 | -77.3% | 3,000 | -85.0% | 0.00% | -100.0% |
| Q2 2019 | $481,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |